• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4624939)   Today's Articles (5659)   Subscriber (49436)
For: Taïeb A, Constans J, Mahon FX. Une nouvelle piste thérapeutique pour les sclérodermies graves: le mésylate d’imatinib. Rev Med Interne 2008;29:173-5. [PMID: 17597261 DOI: 10.1016/j.revmed.2007.05.032] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2007] [Accepted: 05/21/2007] [Indexed: 12/26/2022]
Number Cited by Other Article(s)
1
Verrecchia F, Michel L, Keshtmand H, Wang Y, Launay D, Farge D. Existe-t-il une action antifibrosante spécifique des immunosuppresseurs utilisés pour traiter la sclérodermie systémique ? Rev Med Interne 2009;30:955-62. [DOI: 10.1016/j.revmed.2009.02.019] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2008] [Revised: 02/16/2009] [Accepted: 02/25/2009] [Indexed: 10/20/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA